the SRIW Life Sciences
North America, Wisconsin, United States, Belgium
Description
the SRIW Life Sciences
Investor Profile
the SRIW Life Sciences has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A rounds (top funding stages).
- Majority of deals are located in Belgium.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (67%)
- Series A (33%)
Country Focus
- Belgium (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Biopharma
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.